Unquoted Biotechs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Unquoted Biotechs

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	7/25/2006 2:28:19 PM
	of 253

Inotek - PARP deal done with DNA. inotekcorp.com Inotek Pharmaceuticals Corporation is a private, high-growth, development-stage pharmaceutical company founded in 1996. The Company has leveraged its small molecule chemistry expertise to discover and develop a deep pipeline of therapeutics targeting cell death, DNA repair and inflammatory pathways. Inotek’s lead program is focused on blocking the nuclear DNA repair enzyme, poly (ADP-ribose) polymerase (or PARP), that has broad application in a variety of unmet medical needs. Technology Overview: inotekcorp.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next